FDA's bi­o­log­ics chief Pe­ter Marks pre­views ac­cel­er­at­ed ap­proval guid­ance

The FDA’s Cen­ter for Bi­o­log­ics Eval­u­a­tion and Re­search is plan­ning to re­lease some cru­cial guid­ance soon for CRISPR and gene ther­a­py de­vel­op­ers on plat­form tech­nolo­gies …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER